Main Stories

ImmunityBio: Anktiva Revenue Will Ramp, But Competitive Risks Remain

19/12/2025
admin

ImmunityBio: Anktiva Revenue Will Ramp, But Competitive Risks Remain#ImmunityBio #Anktiva #Revenue #Ramp #Competitive #Risks #Remain

发表评论

您的电子邮箱地址不会被公开。